Primary Care’s Role in Skin Cancer Detection

Expert panelists discuss the essential role of primary care in early skin cancer detection, balancing clinical judgment with emerging AI artificial intelligence tools, and more.

First Blood Test for Alzheimer Disease Diagnosis Cleared by FDA for Primary Care Use: Daily Dose
December 02, 2025

Your daily dose of the clinical news you may have missed.

Why Caregivers Don't Talk About Alzheimer Agitation, With Geriatric NP Carolyn Clevenger, GNP
December 02, 2025

Nearly one-third of caregivers hesitate to discuss agitation in a patient with AD. Emory's Clevenger, shares why and how clinicians can proactively address this barrier.

New Menopause Therapies Reflect a “Sea Change” in Women’s Health, Says Lisa Larkin, MD
December 02, 2025

Lisa Larkin, MD, explains how new therapies like elinzanetant reflect a major shift in menopause care and rising demand for better clinician education.

Baxdrostat Granted FDA Priority Review for Hard-to-Control Hypertension, Could Be First-In-Class Therapy
December 02, 2025

The Priority Review decision is based on phase 3 results showing consistent SBP reductions across uncontrolled and treatment-resistant hypertension subgroups.

Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis
December 02, 2025

Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.

Anti-Tau Antibody Etalanetug Reduces Novel Tau Biomarker in Phase Ib/II Study
December 02, 2025

New findings reveal etalanetug significantly reduces tau biomarkers in Alzheimer’s patients, paving the way for innovative blood-based assessments of tau pathology.

WHO Issues First Guidelines on GLP-1 Receptor Agonists for Obesity Treatment
December 02, 2025

The landmark global policy recognizes obesity as chronic disease requiring lifelong care, warns of inequitable access and proposes 3-pillar strategy targeting prevention, screening, treatment.

Understanding Agitation in Alzheimer's: Why Memory Care Isn't Enough – with Carolyn Clevenger, GNP
December 01, 2025

Emory's Clevenger discusses the neurotransmitter dysregulation behind agitation in AD and why memory-focused care doesn't address behavioral symptoms.

Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care
December 01, 2025

Psychiatric comorbidities affect 25% of AD patients. Here, a check list on when to screen, when to refer, and how to prevent accumulated psychological burden in primary care.

Merck Secures Fast Track for Novel AD Antibody and Reports First-in-Human Data
December 01, 2025

New safety and biomarker results from MK-2214 and MK-1167 advance Merck’s dual approach to Alzheimer therapy.